Literature DB >> 36258720

High-resolution Melting Analysis for NOTCH1 c.7541-7542delCT Mutation in Chronic Lymphocytic Leukemia: Prognostic Significance in Egyptian Patients.

Dalia Sherief1, Asmaa Hassan1, Eman Habeeb1, Nahla Nosair1, Maaly Mabrouk2, Sarah Shoeib2, Heba Reyad3, Tamer Haydra4, Mona Watany2.   

Abstract

The present study aimed to detect the prevalence of NOTCH1 c.7541-7542delCT mutation in Egyptian CLL patients using HRM assay and to assess its relation to patients' survival. The study included 50 newly diagnosed treatment-naïve CLL patients and 50 age and sex matched healthy controls. NOTCH1 c.7541-7542delCT mutation was detected using High-resolution melting (HRM) assay and direct Sanger sequencing. Outcome parameters included progression free survival (PFS) and overall survival (OS). NOTCH1 c.7541-7542delCT mutation was detected in 5 (10.0%) of CLL patients. No controls had NOTCH1 c.7541-7542delCT mutation. Similar results were obtained by direct Sanger sequencing yielding a sensitivity and specificity of 100.0% for HRM in detection of NOTCH1 c.7541-7542delCT mutation in the studied patients. In univariate analysis, predictors of OS included Trisomy 12, high LDH, presence of NOTCH1 c.7541-7542delCT mutation and lack of CR. In multivariate analysis, only lack of CR was found as a significant predictor of OS. HRM analysis is a sensitive method for detection of NOTCH1 c.7541-7542delCT mutation in CLL patients. This mutation may be linked to poor disease prognosis.
© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2022.

Entities:  

Keywords:  Chronic lymphocytic leukemia; DNA sequencing; High-resolution melting analysis; NOTCH1 mutations; Prognosis

Year:  2022        PMID: 36258720      PMCID: PMC9569265          DOI: 10.1007/s12288-022-01535-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.915


  21 in total

1.  NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

Authors:  F Pozzo; T Bittolo; F Arruga; P Bulian; P Macor; E Tissino; B Gizdic; F M Rossi; R Bomben; A Zucchetto; D Benedetti; M Degan; G D'Arena; A Chiarenza; F Zaja; G Pozzato; D Rossi; G Gaidano; G Del Poeta; S Deaglio; V Gattei; M Dal Bo
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

Review 2.  Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.

Authors:  Carlos I Amaya-Chanaga; Laura Z Rassenti
Journal:  Best Pract Res Clin Haematol       Date:  2016-08-10       Impact factor: 3.020

3.  Comparison of high-resolution melting analysis, Sanger sequencing and ARMS for KRAS mutation detection in metastatic colorectal cancer.

Authors:  Haiyan Zhang; Xiaoming Zhang; Jie Wang; Jiang Xian; Xiaodong Chen; Wei Zhang
Journal:  Clin Lab       Date:  2015       Impact factor: 1.138

4.  High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia.

Authors:  Jing-Jing Xu; Fei-Rong Yao; Min Jiang; You-Tao Zhang; Feng Guo
Journal:  Int J Mol Med       Date:  2017-01-05       Impact factor: 4.101

5.  Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.

Authors:  Eva Vavrova; Barbara Kantorova; Barbara Vonkova; Jitka Kabathova; Hana Skuhrova-Francova; Eva Diviskova; Ondrej Letocha; Jana Kotaskova; Yvona Brychtova; Michael Doubek; Jiri Mayer; Sarka Pospisilova
Journal:  Leuk Res       Date:  2017-08-07       Impact factor: 3.156

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

7.  The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.

Authors:  M López-Guerra; S Xargay-Torrent; L Rosich; A Montraveta; J Roldán; A Matas-Céspedes; N Villamor; M Aymerich; C López-Otín; P Pérez-Galán; G Roué; E Campo; D Colomer
Journal:  Leukemia       Date:  2014-04-30       Impact factor: 11.528

8.  Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.

Authors:  Michaela Angelika Ihle; Jana Fassunke; Katharina König; Inga Grünewald; Max Schlaak; Nicole Kreuzberg; Lothar Tietze; Hans-Ulrich Schildhaus; Reinhard Büttner; Sabine Merkelbach-Bruse
Journal:  BMC Cancer       Date:  2014-01-10       Impact factor: 4.430

9.  Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.

Authors:  Elisabeth Silkenstedt; Fabian Arenas; Berta Colom-Sanmartí; Sílvia Xargay-Torrent; Morihiro Higashi; Ariadna Giró; Vanina Rodriguez; Patricia Fuentes; Walter E Aulitzky; Heiko van der Kuip; Sílvia Beà; Maria L Toribio; Elias Campo; Mònica López-Guerra; Dolors Colomer
Journal:  J Exp Clin Cancer Res       Date:  2019-11-01

Review 10.  NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Authors:  Emanuela Rosati; Stefano Baldoni; Filomena De Falco; Beatrice Del Papa; Erica Dorillo; Chiara Rompietti; Elisa Albi; Franca Falzetti; Mauro Di Ianni; Paolo Sportoletti
Journal:  Front Oncol       Date:  2018-06-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.